Overview

Pirfenidone for Progressive Fibrotic Sarcoidosis

Status:
Unknown status
Trial end date:
2020-03-30
Target enrollment:
Participant gender:
Summary
Study comparing pirfenidone versus placebo for patients with advanced fibrotic sarcoidosis
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
Royal Brompton & Harefield NHS Foundation Trust
Treatments:
Pirfenidone